Teshima, T <br/><br/>
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.  [electronic resource] 

 -  The Journal of clinical investigation  Aug 1999 
 - 317-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI7111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Marrow Transplantation--adverse effects<br/>CD4 Antigens--physiology<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cytotoxicity, Immunologic--drug effects<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--immunology<br/>Graft vs Tumor Effect--immunology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Interleukin-11--physiology<br/>Leukemia, Experimental--immunology<br/>Membrane Glycoproteins--physiology<br/>Mice<br/>Mice, Inbred C3H<br/>Mice, Inbred C57BL<br/>Mice, Inbred DBA<br/>Mice, Knockout<br/>Perforin<br/>Pore Forming Cytotoxic Proteins<br/>Sarcoma, Experimental--immunology<br/>T-Lymphocytes, Cytotoxic--drug effects<br/>Tumor Cells, Cultured<br/>fas Receptor--physiology